Target intelligence / Profile preview

ROPN1L antisense RNA 1 (ROPN1L-AS1)

Target: ROPN1L-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA, Non-protein coding gene

Overview

ROPN1L antisense RNA 1 (ROPN1L-AS1) is a long non-coding antisense RNA gene present in humans. It is transcribed from the opposite strand of the ROPN1L gene locus and hypothesized to regulate its expression through RNA-RNA interactions. Like other antisense RNAs, it may participate in the modulation of gene activity at various levels—including epigenetic, transcriptional, and post-transcriptional regulation—though there is no specific functional or disease information available for ROPN1L-AS1 at present.

Other names: ROPN1L antisense RNA 1ROPN1L-AS1

Mechanism of action

Not applicable for drugs; for the molecule itself, common antisense lncRNA mechanisms include transcriptional interference, mRNA degradation, translation suppression, and epigenetic modulation

Biological functions

Regulation of gene expression (by sequence complementarity with ROPN1L mRNA or related genomic loci)Epigenetic regulation (potential; general to antisense lncRNAs)

Disease associations

There is no disease linkage currently reported for ROPN1L-AS1 specifically, but antisense lncRNAs as a broad class are known to be implicated in cancer, genomic imprinting disorders, and possibly other diseases. ROPN1L-AS1’s disease associations are not established.

Safety considerations

None reported or identified for ROPN1L-AS1 as a molecule or target; safety concerns would generally pertain to therapeutic manipulation of antisense RNAs in general, such as off-target gene regulation

Interacting drugs

None known; no drugs reported to interact with ROPN1L-AS1

Biomarkers

None known; ROPN1L-AS1 is not established as a biomarker

Beyond the preview

Go deeper on ROPN1L antisense RNA 1 (ROPN1L-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ROPN1L antisense RNA 1 (ROPN1L-AS1).

Explore the full profile